KAIROS PHARMA, LTD. (KAPA) Net income 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$5.4MFY2025 · since FY2023: -$1.8M → -$5.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.4M | -109.3% |
| FY2024 | -$2.6M | -43.7% |
| FY2023 | -$1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice